Chemokine Receptors as Biomarkers in Head and Neck Squamous Cell Carcinoma
Journal: Journal of Oncobiomarkers (Vol.1, No. 1)Publication Date: 2014-06-30
Authors : Yuning Hou; Chunying Li;
Page : 1-3
Keywords : ;
Abstract
Head and neck squamous cell carcinoma (HNSCC) is reported to be the 6th most common solid tumor diagnosed in the world [1]. Around 95% head and neck cancers are squamous cell carcinomas originating in the upper aerodigestive epithelial cells [2]. Despite continuous research efforts and progresses in diagnostic and therapeutic strategies, the mortality rates have not significantly changed over the past several decades [3]. Moreover, the five-year survival rate of HNSCC after diagnosis is considerably lower than that of other cancers, such as cervix, colorectal and breast cancer [4,5]. The reason for the limited five-year survival rate of HNSCC could be advanced disease stages, failure in early diagnosis and low efficiency of therapeutic strategies [6,7]. The death of HNSCC is mainly caused by invasion along with regional and/or distant metastatic spreading of tumor cells from primary tumor lesions [8]. Therefore, the key point of the treatment of head and neck cancers is early diagnosis.
Other Latest Articles
- A Gateway between Omics Data and Systems Biology
- Extraction of Molecular Features through Exome to Transcriptome Alignment
- The Hunt for Biomarkers of Autism Spectrum Disorders
- “Not Guilty by Reason of Insanity”: Common Characteristics in Six Homicide Cases from Hatay, Turkey
- A New DFO Method for Developing Latent Fingermarks on Thermal Paper
Last modified: 2015-06-23 18:51:56